IP Library Granted Patent US 12,331,146
Granted Patent B2
US 12,331,146 · App. 18/485,795 · Granted Jun 17, 2025

Polymer compositions containing grafted polymeric networks and processes for their preparation and use

Inventors: Brian Aitken (Jacksonville, FL); Charles Scales (St. Augustine, FL); Scott Joslin (Ponte Vedra Beach, FL); Yong Zhang (Jacksonville, FL); Dola Sinha (Jacksonville, FL); Shivkumar Mahadevan (Jacksonville, FL); Patricia Martin (Jacksonville, FL); Fang Lu (St. Augustine, FL); Donnie Duis (Jacksonville, FL); Stephen C. Arnold (Jacksonville, FL)
Assignee: Johnson & Johnson Vision Care, Inc.
C08F283/124C08F290/068C08J7/16C08L51/085C09B69/109G02B1/043C08L2201/50C08L2203/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,331,146
App. No.
18/485,795
Granted
Jun 17, 2025
Kind
B2
Abstract

Provided are polymer compositions made by a process comprising: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator, (c) combining the crosslinked substrate network with a second reactive composition containing one or more ethylenically unsaturated compounds; and (d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the second reactive composition polymerizes therein with the crosslinked substrate network to form a grafted polymeric network and a byproduct polymer. Also provided are precursors to the polymer compositions, processes for preparation of the polymer compositions, and methods of using the polymer compositions, for instance in medical devices.

Claims (28)

1. A polymer composition formed by a process comprising:

(a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker;

(b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator;

(c) combining the crosslinked substrate network with a second reactive composition containing one or more ethylenically unsaturated compounds; and

(d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the second reactive composition polymerizes therein with the crosslinked substrate network to form a grafted polymeric network and a byproduct polymer.

2. The polymer composition of claim 1 wherein step (d) is conducted in the presence of a crosslinker such that the byproduct polymer is covalently bound with the grafted polymeric network.

3. The polymer composition of claim 1 wherein step (d) is conducted in the substantial absence of a crosslinker such that at least a portion of the byproduct polymer is not covalently bound to the grafted polymeric network.

4. The polymer composition of claim 1 wherein the one or more ethylenically unsaturated compounds of step (a) comprise one or more reactive groups independently selected from: (meth)acrylate, (meth)acrylamide, styryl, vinyl, N-vinyl lactam, N-vinylamide, O-vinylether, O-vinylcarbonate, O-vinylcarbamate, C 2-12 alkenyl, C 2-12 alkenylphenyl, C 2-12 alkenylnaphthyl, and C 2-6 alkenylphenyl-C 1-6 alkyl.

5. The polymer composition of claim 1 wherein the one or more ethylenically unsaturated compounds of step (c) comprise one or more reactive groups independently selected from: (meth)acrylate, (meth)acrylamide, styryl, vinyl, N-vinyl lactam, N-vinylamide, O-vinylether, O-vinylcarbonate, O-vinylcarbamate, C 2-12 alkenyl, C 2-12 alkenylphenyl, C 2-12 alkenylnaphthyl, and C 2-6 alkenylphenyl-C 1-6 alkyl.

6. The polymer composition of claim 1 wherein the polymerization initiator is a bisacylphosphine oxide, a bisacylphosphane oxide, a di-azo compound, a di-peroxide compound, an azo-bis(monoacylphosphine oxide), an azo-bis(monoacylphosphane oxide), a peroxy-bis(monoacylphosphine oxide), a peroxy-bis(monoacylphosphane oxide), an azo-bis(alpha-hydroxy ketone), a peroxy-bis(alpha-hydroxy ketone), an azo-bis(1,2-diketone), a peroxy-bis(1,2-diketone), a germanium based compound, tert-butyl 7-methyl-7-(tert-butylazo) peroxyoctanoate, or combinations thereof.

7. The polymer composition of claim 1 wherein the polymerization initiator is a bisacylphosphine oxide or a bis(acyl)phosphane oxide.

8. The polymer composition of claim 1 that is in the form of a hydrogel and wherein the first reactive composition contains silicone reactive components and the second reactive composition contains hydrophilic reactive components.

9. The polymer composition of claim 1 that is in the form of a hydrogel and wherein the first reactive composition contains hydrophilic reactive components and the second reactive composition contains silicone reactive components.

10. The polymer composition of claim 1 wherein the first reactive composition further comprises one or more of a polyamide, a UV-VIS absorber, a dye, a tint, a pigment, an antimicrobial, a pharmaceutical, and a nutraceutical.

11. The polymer composition of claim 1 wherein the second reactive composition further comprises one or more of a polyamide, a UV-VIS absorber, a dye, a tint, a pigment, an antimicrobial, a pharmaceutical, and a nutraceutical.

12. A medical device comprising the polymer composition of claim 1 .

13. An ophthalmic device comprising the polymer composition of claim 1 .

14. The ophthalmic device of claim 13 selected from the group consisting of a contact lens, an intraocular lens, a punctal plug and an ocular insert.

15. A contact lens comprising a polymer composition, wherein the polymer composition is formed by the process of claim 1 .

16. The contact lens of claim 15 wherein the first reactive composition, the second reactive composition, or both the first reactive composition and the second reactive composition contain one or more additives selected from UV absorbers, photochromic compounds, pharmaceutical compounds, nutraceutical compounds, antimicrobial compounds, reactive tints, pigments, copolymerizable dyes, non-polymerizable dyes, release agents, wetting agents, and release agents.

17. A contact lens comprised of a crosslinked substrate network, wherein the crosslinked substrate network contains containing a covalently bound activatable free radical initiator, wherein the crosslinked substrate network is formed by a process comprising:

(a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds comprising a silicone-containing component having at least one reactive group and at least one siloxane group; and (iii) a crosslinker; and

(b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form the crosslinked substrate network containing a covalently bound activatable free radical initiator.

18. A process for making a polymer composition, the process comprising:

(a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker;

(b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator;

(c) combining the crosslinked substrate network with a second reactive composition containing one or more ethylenically unsaturated compounds; and

(d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the second reactive composition polymerizes therein with the crosslinked substrate network to form a grafted polymeric network and a byproduct polymer.

Continuity (4)
Continuation 17242948 · Apr 28, 2021
Continuation 15656033 · Jul 21, 2017
Provisional Application 62371362 · Aug 5, 2016
Related Publication 20240043598A1 · Feb 8, 2024
References Cited (197)
US 3408429A · Otto · 1968 [cited by applicant]
US 3660545A · Wichterle · 1972 [cited by applicant]
US 3808178A · Gaylord · 1974 [cited by applicant]
US 4018853A · Le et al. · 1977 [cited by applicant]
US 4099859A · Merrill · 1978 [cited by applicant]
US 4113224A · Clark et al. · 1978 [cited by applicant]
US 4120570A · Gaylord · 1978 [cited by applicant]
US 4136250A · Mueller et al. · 1979 [cited by applicant]
US 4153641A · Deichert et al. · 1979 [cited by applicant]
US 4190277A · England · 1980 [cited by applicant]
US 4197266A · Clark et al. · 1980 [cited by applicant]
US 4680336A · Larsen et al. · 1987 [cited by applicant]
US 4740533A · Su et al. · 1988 [cited by applicant]
US 4892402A · Sawamoto et al. · 1990 [cited by applicant]
US 4910277A · Bambury et al. · 1990 [cited by applicant]
US 4943150A · Deichert et al. · 1990 [cited by applicant]
US 5034461A · Lai et al. · 1991 [cited by applicant]
US 5039459A · Kindt-larsen et al. · 1991 [cited by applicant]
US 5070215A · Bambury et al. · 1991 [cited by applicant]
US 5236969A · Kunzler et al. · 1993 [cited by applicant]
US 5244981A · Seidner et al. · 1993 [cited by applicant]
US 5258024A · Chavel et al. · 1993 [cited by applicant]
US 5310779A · Lai · 1994 [cited by applicant]
US 5314960A · Spinelli et al. · 1994 [cited by applicant]
US 5321108A · Kunzler et al. · 1994 [cited by applicant]
US 5331067A · Seidner et al. · 1994 [cited by applicant]
US 5371147A · Spinelli et al. · 1994 [cited by applicant]
US 5387662A · Kunzler et al. · 1995 [cited by applicant]
US 5539016A · Kunzler et al. · 1996 [cited by applicant]
US 5726733A · Lai et al. · 1998 [cited by applicant]
US 5760100A · Nicolson et al. · 1998 [cited by applicant]
US 5849811A · Nicolson et al. · 1998 [cited by applicant]
US 5944853A · Molock et al. · 1999 [cited by applicant]
US 5962548A · Vanderlaan et al. · 1999 [cited by applicant]
US 5965631A · Nicolson et al. · 1999 [cited by applicant]
US 5998498A · Vanderlaan et al. · 1999 [cited by applicant]
US 6020445A · Vanderlaan et al. · 2000 [cited by applicant]
US 6367929B1 · Maiden et al. · 2002 [cited by applicant]
US 6372815B1 · Sulc et al. · 2002 [cited by applicant]
US 6586038B1 · Chabrecek · 2003 [cited by applicant]
US 6617373B2 · Sulc et al. · 2003 [cited by applicant]
US 6822016B2 · McCabe et al. · 2004 [cited by applicant]
US 6867245B2 · Iwata et al. · 2005 [cited by applicant]
US 6943203B2 · Vanderlaan et al. · 2005 [cited by applicant]
US 6951894B1 · Nicolson et al. · 2005 [cited by applicant]
US 6992118B2 · Sulc et al. · 2006 [cited by applicant]
US 7247692B2 · Laredo · 2007 [cited by applicant]
US 7262232B2 · Sulc et al. · 2007 [cited by applicant]
US 7396890B2 · Zanini et al. · 2008 [cited by applicant]
US 7461937B2 · Steffen et al. · 2008 [cited by applicant]
US 7468398B2 · Nicolson et al. · 2008 [cited by applicant]
US 7538146B2 · Nicolson et al. · 2009 [cited by applicant]
US 7553880B2 · Nicolson et al. · 2009 [cited by applicant]
US 7572841B2 · Chen et al. · 2009 [cited by applicant]
US 7649027B2 · Imai · 2010 [cited by applicant]
US 7666921B2 · McCabe et al. · 2010 [cited by applicant]
US 7691916B2 · McCabe et al. · 2010 [cited by applicant]
US 7786185B2 · Rathore et al. · 2010 [cited by applicant]
US 7825170B2 · Steffen et al. · 2010 [cited by applicant]
US 7905594B2 · Widman et al. · 2011 [cited by applicant]
US 7915323B2 · Awasthi et al. · 2011 [cited by applicant]
US 7994356B2 · Awasthi et al. · 2011 [cited by applicant]
US 8022158B2 · Rathore et al. · 2011 [cited by applicant]
US 8157373B2 · Widman et al. · 2012 [cited by applicant]
US 8163206B2 · Chang et al. · 2012 [cited by applicant]
US 8240849B2 · Widman et al. · 2012 [cited by applicant]
US 8273802B2 · Laredo et al. · 2012 [cited by applicant]
US 8313828B2 · Widman et al. · 2012 [cited by applicant]
US 8317505B2 · Widman et al. · 2012 [cited by applicant]
US 8318055B2 · Widman et al. · 2012 [cited by applicant]
US 8399538B2 · Steffen et al. · 2013 [cited by applicant]
US 8415404B2 · Nicolson et al. · 2013 [cited by applicant]
US 8415405B2 · Maggio et al. · 2013 [cited by applicant]
US 8420711B2 · Awasthi et al. · 2013 [cited by applicant]
US 8450387B2 · McCabe et al. · 2013 [cited by applicant]
US 8487058B2 · Liu et al. · 2013 [cited by applicant]
US 8568626B2 · Nicolson et al. · 2013 [cited by applicant]
US 8795558B2 · Widman et al. · 2014 [cited by applicant]
US 8883872B2 · Gruützmacher et al. · 2014 [cited by applicant]
US 8937110B2 · Alli et al. · 2015 [cited by applicant]
US 8937111B2 · Alli et al. · 2015 [cited by applicant]
US 8940812B2 · Reboul et al. · 2015 [cited by applicant]
US 8980972B2 · Driver · 2015 [cited by applicant]
US 9056878B2 · Fujisawa et al. · 2015 [cited by applicant]
US 9075186B2 · Widman et al. · 2015 [cited by applicant]
US 9120900B2 · Grutzmacher et al. · 2015 [cited by applicant]
US 9125808B2 · Alli et al. · 2015 [cited by applicant]
US 9140825B2 · Alli et al. · 2015 [cited by applicant]
US 9156934B2 · Alli et al. · 2015 [cited by applicant]
US 9170349B2 · Mahadevan et al. · 2015 [cited by applicant]
US 9180633B2 · Widman et al. · 2015 [cited by applicant]
US 9180634B2 · Widman et al. · 2015 [cited by applicant]
US 9217813B2 · Liu et al. · 2015 [cited by applicant]
US 9244196B2 · Scales et al. · 2016 [cited by applicant]
US 9244197B2 · Alli et al. · 2016 [cited by applicant]
US 9260544B2 · Rathore et al. · 2016 [cited by applicant]
US 9297928B2 · Molock et al. · 2016 [cited by applicant]
US 9297929B2 · Scales et al. · 2016 [cited by applicant]
US 9297930B2 · Nakamura et al. · 2016 [cited by applicant]
US 9417464B2 · Wildsmith et al. · 2016 [cited by applicant]
US 9453944B2 · Saxena et al. · 2016 [cited by applicant]
US 9610742B2 · Widman · 2017 [cited by applicant]
US 9857607B2 · Widman et al. · 2018 [cited by applicant]
US 9927633B2 · Franklin et al. · 2018 [cited by applicant]
US 10073192B2 · Scales et al. · 2018 [cited by applicant]
US 10961341B2 · Aitken et al. · 2021 [cited by applicant]
US 11021558B2 · Aitken · 2021 [cited by examiner]
US 11034789B2 · Aitken et al. · 2021 [cited by applicant]
US 11820850B2 · Aitken · 2023 [cited by examiner]
US 20010007880A1 · Marchin et al. · 2001 [cited by applicant]
US 20020016383A1 · Iwata et al. · 2002 [cited by applicant]
US 20030162862A1 · Mccabe et al. · 2003 [cited by applicant]
US 20060043623A1 · Powell et al. · 2006 [cited by applicant]
US 20060142410A1 · Baba · 2006 [cited by examiner]
US 20060227287A1 · Molock et al. · 2006 [cited by applicant]
US 20100120939A1 · Phelan · 2010 [cited by applicant]
US 20120142805A1 · Grutzmacher · 2012 [cited by examiner]
US 20130168617A1 · Alli et al. · 2013 [cited by applicant]
US 20130172440A1 · Alli et al. · 2013 [cited by applicant]
US 20130176529A1 · Li · 2013 [cited by examiner]
US 20130217620A1 · Alli et al. · 2013 [cited by applicant]
US 20140024791A1 · Alli et al. · 2014 [cited by applicant]
US 20140031447A1 · Alli et al. · 2014 [cited by applicant]
US 20140171542A1 · Chang · 2014 [cited by applicant]
US 20150094395A1 · Alli et al. · 2015 [cited by applicant]
US 20150146159A1 · Archer et al. · 2015 [cited by applicant]
US 20230176251A1 · Widman et al. · 2023 [cited by applicant]
US 20240325597A1 · Widman et al. · 2024 [cited by applicant]
EP 0080539B1 · 1986 [cited by applicant]
EP 0632329A1 · 1995 [cited by applicant]
EP 1286823B1 · 2009 [cited by applicant]
EP 2238482B1 · 2013 [cited by applicant]
EP 2598302B1 · 2014 [cited by applicant]
JP S51139848A · 1976 [cited by applicant]
JP 2009223158A · 2009 [cited by applicant]
JP 2015500913A · 2015 [cited by applicant]
RU 1789208A1 · 1993 [cited by applicant]
RU 2334770C1 · 2008 [cited by applicant]
RU 2497160C2 · 2013 [cited by applicant]
SU 694078A3 · 1979 [cited by applicant]
SU 1085986A1 · 1984 [cited by applicant]
SU 1500316A1 · 1989 [cited by applicant]
WO 9631792A1 · 1996 [cited by applicant]
WO 9749768A1 · 1997 [cited by applicant]
WO 1999029750A1 · 1999 [cited by applicant]
WO 2000002937A1 · 2000 [cited by applicant]
WO 2001030512A2 · 2001 [cited by applicant]
WO 2001078971A1 · 2001 [cited by applicant]
WO 2003022321A2 · 2003 [cited by applicant]
WO 2003022322A2 · 2003 [cited by applicant]
WO 2004063795A1 · 2004 [cited by applicant]
WO 2008000361A1 · 2008 [cited by applicant]
WO WO2008003601A1 · 2008 [cited by examiner]
WO 2009026659A1 · 2009 [cited by applicant]
WO 2010121387A1 · 2010 [cited by applicant]
WO 2013090790A1 · 2013 [cited by applicant]
WO 2013096597A1 · 2013 [cited by applicant]
WO 2013177523A2 · 2013 [cited by applicant]
WO 2015038577A1 · 2015 [cited by applicant]
WO 2015200173A1 · 2015 [cited by applicant]
WO 2016100457A1 · 2016 [cited by applicant]
WO 2017106322A1 · 2017 [cited by applicant]
WO 2018009312A1 · 2018 [cited by applicant]
WO 2018026822A1 · 2018 [cited by applicant]
WO 2023275683A1 · 2023 [cited by applicant]
Allred et al, Adducts of Group IV Tetrahalides and β-Diketones, Inorganic Chemistry, vol. 7, No. 6, pp. 1196-1201, Jun. 1968. [cited by applicant]
Beil, et al., “Bisacylphosphane oxides as photo-latent cytotoxic agents and potential photo-latent anticancer drugs”, In Scientific Reports, vol. 9:6003, pp. 1-11, Apr. 12, 2019. [cited by applicant]
Corrales et al, Free radical macrophotoinitiators: an overview on recent advances, Journal of Photochemistry and Photobiology A: Chemistry, vol. 159 (2003), pp. 103-114. [cited by applicant]
Cremer et al, Molecular Mechanism for the Interactions of Hofmeister Cations with Macromolecules in Aqueous Solution, Journal of Amercian Chemistry Society, vol. 142, pp. 19094-19100, 2020. [cited by applicant]
De Groot et al, Hydrophilic Polymeric Acylphospine Oxide Photoinitiators/Crosslinkers for in Vivo Blue-Light Photopolymerization, Biomacromolecules, 2001, vol. 2, pp. 1271-1278. [cited by applicant]
Engel et al, An Aliphatic Bifunctional Free Radical Initiator. Synthese of a Block Copolymer froman Azoperester by Sequential Thermal and Photochemical Initiation, Macromolecules 2003, vol. 36, pp. 3821-3825. [cited by applicant]
Franz et al, NMR Quantification of the Effects of Ligands and Counterions on Lewis Acid Catalysis, The Journal of Organic Chemistry, vol. 84, pp. 15845-15853, 2019. [cited by applicant]
Gunersel et al, Bisacylphosphine Oxides as bifunctional Photoinitiators for block copolymer synthesis, Die Angewandte Makromolekulare Chemie, vol. 264 Nr. 4604, (1999), pp. 88-91. [cited by applicant]
International Preliminary Report on Patentability, dated Aug. 4, 2020, for PCT Int'l Appln. No. PCT/IB2019/050427. [cited by applicant]
International Preliminary Report on Patentability, dated Aug. 4, 2020, for PCT Int'l Appln. No. PCT/IB2019/050428. [cited by applicant]
International Preliminary Report on Patentability, dated Feb. 5, 2019, for PCT Int'l Appln. No. PCT/US2017/044912. [cited by applicant]
International Search Report, dated Oct. 30, 2017, for PCT Int'l Appln. No. PCT/US2017/044912. [cited by applicant]
International Search Report, dated Jul. 17, 2019, for PCT Int'l Appln. No. PCT/IB2019/050427. [cited by applicant]
International Search Report, dated Jul. 17, 2019, for PCT Int'l Appln. No. PCT/IB2019/050428. [cited by applicant]
ISO 18369-4, “Ophthalmic Optics—Contact Lenses—Part 4: Physicochemical Properties of Contact Lens Materials”, In International Organization for Standardization, 38 Pages, Aug. 15, 2006. [cited by applicant]
ISO 9913-1, “Optics and Optical Instruments—Contact Lenses—Part 1: Determination of Oxygen Permeability and Transmissibility by the FATT Method”, In International Organization for Standardization, 16 Pages, Nov. 1, 1996. [cited by applicant]
Jockusch et al, A Steady-State and Picosecond Pump-Probe Investigation of the Photophysics of an Acyl and a Bis(acyl)phosphine Oxide, J. Am. Chem. Soc., vol. 119, No. 47, 1997, pp. 11495-11501. [cited by applicant]
Jockusch et al, Phosphinoyl Radicals: Structure and Reactivity. A Laser Flash Photolysis and Time-Resolved ESR Investigation, J. Am. Chem. Soc., vol. 120, No. 45, 1998, pp. 11773-11777. [cited by applicant]
Kolczak, et al, “Reaction Mechanism of Moacyl- and Bisacylphosphine Oxide Photoinitiators Studied by 31P-, 13C-, and 1H-CIDNP and ESR” in J. Am. Chem. Soc., 1996, 118, pp. 6477-6489. [cited by applicant]
PubChem: Triphenylphosphine Oxide, National Library of Medicine (NIH), downloaded Feb. 21, 2023. [https://pubchem.ncbi.nlm.nih.gov/compound/13097]. [cited by applicant]
Rode et al, Metal NMR investigations on the binding of dicarbonyl-ligands to alkali and alkaline earth ions, Inorganica Chimica Acta, vol. 48, pp. 135-137, 1981. [cited by applicant]
Sitzmann, Critical photoinitiators for UV-LED Curing: Enabling 3D Printing, Inks and Coatings, BASF, Redondo Beach, CA, Mar. 10, 2015. [cited by applicant]
Stepen et al., “Electrophilic Phosphonium Cation-Mediated Phosphane Oxide Reduction Using Oxalyl Chloride and Hydrogen”, Angew. Chem. Int. Ed., 57, pp. 15253-15256, 2018. [cited by applicant]
Waters et al, Structure and Mechanism of Strength Enhancement in Interpenetrating Polymer Network Hydrogels, Macromolecules 2011, vol. 44, pp. 5776-5787. [cited by applicant]
International Preliminary Report on Patentability dated Dec. 14, 2023 for PCT/IB2022/055845. [cited by applicant]
“Helios Quartz UV Lamps Information Sheet”, 32 pages. No Date. [cited by applicant]
Extended European Search Report, received for European Application No. 20171047.2. mailed on Nov. 20, 2020, 5 pages. [cited by applicant]
Greivenkamp, John E., “Field Guide to Geometrical Optics”, SPIE Field Guides, vol. FG01, 12 p. 2004. [cited by applicant]
International Search Report and Written Opinion, received for PCT Application No. PCT/IB2022/055845, mailed on Dec. 14, 2022, 9 pages. [cited by applicant]
International Search Report and Written Opinion, received for PCT Application No. PCT/IB2024/051680, mailed on Aug. 5, 2024, 12 pages. [cited by applicant]
Lima et al., “Increased Rates of Photopolymerisation by Ternary Type II Photoinitiator Systems in Dental Resins”, Journal of the Mechanical Behavior of Biomedical Materials, vol. 98, pp. 71-78, 2019. [cited by applicant]
Ruhland et al., “Quantification and Elucidation of the UV-light Triggered Initiation Kinetics of TPO and BAPO in Liquid Acrylate Monomer”, Journal of Applied Polymer Science, vol. 137, No. 6, pp. 1-16, 2019. [cited by applicant]